Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorRehm, Jürgen
dc.contributor.authorAnderson, Peter
dc.contributor.authorArbesu, Jose Angel
dc.contributor.authorArmstrong, Iain
dc.contributor.authorAubin, Henri-Jean
dc.contributor.authorBachmann, Michael
dc.contributor.authorColom-Farran, Joan
dc.contributor.authorSegura-García, Lidia
dc.date.accessioned2022-02-08T14:16:02Z
dc.date.available2022-02-08T14:16:02Z
dc.date.issued2017-09-28
dc.identifier.citationRehm J, Anderson P, Arbesu Prieto JA, Armstrong I, Aubin HJ, Bachmann M, et al. Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med. 2017 Sep 28;15(1):173.
dc.identifier.issn1741-7015
dc.identifier.urihttps://hdl.handle.net/11351/6990
dc.descriptionAlcohol use; Blood pressure; Primary healthcare; Recommendations
dc.description.abstractBackground: Hazardous and harmful alcohol use and high blood pressure are central risk factors related to premature non-communicable disease (NCD) mortality worldwide. A reduction in the prevalence of both risk factors has been suggested as a route to reach the global NCD targets. This study aims to highlight that screening and interventions for hypertension and hazardous and harmful alcohol use in primary healthcare can contribute substantially to achieving the NCD targets. Methods: A consensus conference based on systematic reviews, meta-analyses, clinical guidelines, experimental studies, and statistical modelling which had been presented and discussed in five preparatory meetings, was undertaken. Specifically, we modelled changes in blood pressure distributions and potential lives saved for the five largest European countries if screening and appropriate intervention rates in primary healthcare settings were increased. Recommendations to handle alcohol-induced hypertension in primary healthcare settings were derived at the conference, and their degree of evidence was graded. Results: Screening and appropriate interventions for hazardous alcohol use and use disorders could lower blood pressure levels, but there is a lack in implementing these measures in European primary healthcare. Recommendations included (1) an increase in screening for hypertension (evidence grade: high), (2) an increase in screening and brief advice on hazardous and harmful drinking for people with newly detected hypertension by physicians, nurses, and other healthcare professionals (evidence grade: high), (3) the conduct of clinical management of less severe alcohol use disorders for incident people with hypertension in primary healthcare (evidence grade: moderate), and (4) screening for alcohol use in hypertension that is not well controlled (evidence grade: moderate). The first three measures were estimated to result in a decreased hypertension prevalence and hundreds of saved lives annually in the examined countries. Conclusions: The implementation of the outlined recommendations could contribute to reducing the burden associated with hypertension and hazardous and harmful alcohol use and thus to achievement of the NCD targets. Implementation should be conducted in controlled settings with evaluation, including, but not limited to, economic evaluation.
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.ispartofseriesBMC medicine;15(1)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHipertensió - Estudi de casos
dc.subjectAlcoholisme - Estudi de casos
dc.subjectAtenció primària - Unió Europea
dc.subject.meshAlcoholism
dc.subject.meshHypertension
dc.subject.mesh/prevention & control
dc.subject.meshPrimary Health Care
dc.subject.meshEuropean Union
dc.titleTowards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s12916-017-0934-1
dc.subject.decsalcoholismo
dc.subject.decshipertensión
dc.subject.decs/prevención & control
dc.subject.decsatención primaria de la salud
dc.subject.decsUnión Europea
dc.relation.publishversionhttps://doi.org/10.1186/s12916-017-0934-1
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Rehm J] Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada. Addiction Policy, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Institute of Medical Science, University of Toronto, Faculty of Medicine, Medical Sciences Building, Toronto, Canada. Department of Psychiatry, University of Toronto, Toronto, Canada. Institute of Clinical Psychology and Psychotherapy, Technische Universität Dresden, Dresden, Germany. [Anderson P] Substance Use, Policy and Practice, Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK. Alcohol and Health, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands. [Arbesu Prieto JA] Primary Care Center La Eria, Oviedo, Spain. Primary Care Spanish Society SEMERGEN, Madrid, Spain. [Armstrong I] Health and Wellbeing Directorate, Public Health England, London, UK. [Aubin HJ] CESP, University Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, APHP, Hôpitaux Universitaires Paris-Sud, Villejuif, France. [Bachmann M] Copentown Healthcare Consultants, Cape Town, South Africa. [Colom J, Segura-Garcia L] Programa d’Abús de Substàncies, Agència Pública de Salut de Catalunya, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
dc.identifier.pmid28954635
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record